Public Health Initiative on Alcohol Flushing (AIAC)

Stanford University

Status: Invitation-only

Conditions: Alcohol Toxicity

Treatments: Genetic: ALDH2 Genotyping

Study type: Interventional

Funder types: Other

Identifiers

NCT06397716

71764

Details and patient eligibility

About

The overall aim of the study is to raise awareness of alcohol flushing and its health risks to the general population.

The primary objective is to see if spreading awareness of the health risks of alcohol flushing and understanding personalized genotype information will lead to changes in alcohol consumption behavior.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adult age over 18
• Native English speaker

Exclusion criteria

• None

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups, including a placebo group

Genotype Revealed

Experimental group

Description:

Subjects with ALDH2 mutation will be notified of positive genotype results after testing completed.

Treatment:

Genetic: ALDH2 Genotyping

Gentoype Not-Revealed

Placebo Comparator group

Description:

Subjects with ALDH2 mutation will not be notified of positive genotype results until after study completed.

Treatment:

Genetic: ALDH2 Genotyping